4//SEC Filing
FORMELA JEAN FRANCOIS 4
Accession 0000950170-24-071303
CIK 0001835579other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:15 PM ET
Size
5.9 KB
Accession
0000950170-24-071303
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-07+17,520→ 17,520 totalExercise: $1.75Exp: 2034-06-06→ Common Stock (17,520 underlying)
Footnotes (2)
- [F1]This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.
- [F2]The Reporting Person is a member of Atlas Venture Associates X, LLC and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the option to Atlas Venture Life Science Advisors, LLC. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001030575
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:15 PM ET
- Size
- 5.9 KB